Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Remember to consult with your healthcare provider about any concerns or side effects you may experience during your treatment
Molecular Identity Developer Eli Lilly Brand Names Mounjaro (diabetes), Zepbound (obesity) Mechanism Dual GLP-1 and GIP receptor agonist FDA Status Approved (2022 diabetes, 2023 obesity) Administration Weekly subcutaneous GIP Receptor Pathway The GIP receptor activation in Tirzepatide provides different metabolic effects than glucagon: Incretin enhancement: GIP augments GLP-1's insulin-related signaling Adipose tissue effects: GIP receptor expression in fat tissue documented Tolerability profile: Some research suggests GIP may moderate GI effects Synergistic incretin signaling: Two incretin pathways vs
Heres how they compare: Effectiveness: Mounjaro: 26% average weight loss after one year Orlistat: 4-8% average weight loss after one year Cost: Mounjaro: ~150-299 per month through private prescription Orlistat: Around 18 per month over-the-counter Availability: Mounjaro: Prescription only with ongoing medical supervision Orlistat: Available over the counter (60mg) or prescription (120mg) Take home message While Mounjaro isnt available over the counter, it can be accessed through private prescription if you meet the eligibility criteria
Anti-Aging Clear Brain Fog Improve Mental Clarity Support Recovery NAD+ Injections NAD+ (Nicotinamide Adenine Dinucleotide) is a powerful coenzyme found in every cell of your body, playing a key role in energy production, DNA repair, and overall cellular function
Curr DiabRep 20:19 Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Targher G (2021) Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled trials
The workouts are
